Introduction

This page provides a comprehensive analysis of the known insider trading history of Megan E Pace. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Megan E Pace has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:VRTX / Vertex Pharmaceuticals Incorporated SVP, Corp. Communications 43,350
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Megan E Pace. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Megan E Pace as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2014-11-19 2014-11-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -33 43,350 -0.08 111.93 -3,694 4,852,166
2014-11-03 2014-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20,000 43,350 85.65 0.01 200 434
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -6,875 48,125 -12.50
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -6,875 48,125 -12.50
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -17,157 28,593 -37.50
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -15,250 15,250 -50.00
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -3,532 4,218 -45.57
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -5,625 1,875 -75.00
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -1,172 2,344 -33.33
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11,629 23,350 -33.25 113.90 -1,324,543 2,659,565
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15,400 34,979 -30.57 113.08 -1,741,432 3,955,425
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -21,881 50,379 -30.28 112.21 -2,455,267 5,653,028
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7,576 72,260 -9.49 111.32 -843,360 8,043,983
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6,875 79,836 9.42 77.31 531,506 6,172,121
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6,875 72,961 10.40 83.36 573,100 6,082,029
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 17,157 66,086 35.07 45.11 773,952 2,981,139
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 15,250 48,929 45.28 48.74 743,285 2,384,799
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3,532 33,679 11.72 37.86 133,722 1,275,087
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,625 30,147 22.94 51.75 291,094 1,560,107
2014-10-01 2014-09-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1,172 24,522 5.02 38.80 45,474 951,454
2014-07-17 2014-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 27,500 27,500
2014-06-26 2014-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (righty to buy)
M - Exercise -5,234 3,516 -59.82
2014-06-26 2014-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -7,500 0 -100.00
2014-06-26 2014-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -12,734 23,350 -35.29 98.03 -1,248,314 2,289,000
2014-06-26 2014-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,234 36,084 16.97 38.80 203,079 1,400,059
2014-06-26 2014-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 7,500 30,850 32.12 37.29 279,675 1,150,396
2014-05-19 2014-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -22 23,350 -0.09 67.00 -1,474 1,564,450
2014-05-19 2014-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -347 23,372 -1.46 65.57 -22,753 1,532,502
2014-05-06 2014-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 23,350 -0.43 69.42 -6,942 1,620,957
2014-05-06 2014-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 23,450 -1.68 67.94 -27,176 1,593,193
2014-05-06 2014-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 23,850 -2.05 67.01 -33,505 1,598,188
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 55,000 55,000
2014-02-07 2014-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14,250 24,350 141.09 0.01 142 244
2014-01-23 2014-01-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1,250 10,100 -11.01 85.00 -106,250 858,500
2014-01-08 2014-01-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -838 11,350 -6.88 75.00 -62,850 851,250
2013-12-12 2013-12-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5,083 12,188 -29.43 65.48 -332,835 798,070
2013-11-19 2013-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -93 17,271 -0.54 60.97 -5,670 1,053,013
2013-08-01 2013-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 27,500 27,500
2013-07-15 2013-07-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -5,000 8,750 -36.36
2013-07-15 2013-07-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5,000 17,271 -22.45 86.00 -430,000 1,485,306
2013-07-15 2013-07-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -678 22,271 -2.95 85.00 -57,630 1,893,035
2013-07-15 2013-07-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 22,949 27.86 38.80 194,000 890,421
2013-07-15 2013-07-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -5,000 13,750 -26.67
2013-07-15 2013-07-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5,000 17,949 -21.79 84.00 -420,000 1,507,716
2013-07-15 2013-07-11 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5,000 22,949 27.86 38.80 194,000 890,421
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -3,500 7,750 -31.11
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
M - Exercise -22,500 7,500 -75.00
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4,100 17,949 -18.59 82.46 -338,086 1,480,075
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3,400 22,049 -13.36 81.54 -277,236 1,797,875
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -21,203 25,449 -45.45 80.48 -1,706,417 2,048,136
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3,500 46,652 8.11 37.86 132,510 1,766,245
2013-07-10 2013-07-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 22,500 43,152 108.95 37.29 839,025 1,609,138
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 45,750 45,750
2013-02-07 2013-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10,166 19,915 104.28 0.01 102 199
2012-07-26 2012-07-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy)
A - Award 30,500 30,500
2012-07-26 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
9,749
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)